Health
Mutant gene-targeted immunotherapy approach developed – Medical Xpress
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy…
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.
The researchers targeted their immunotherapy approach to alterations in the common cancer-related p53 tumor suppressor gene, the RAS tumor-promoting oncogene or T-cell receptor genes. They also tested the therapy…
-
Noosa News20 hours agoWhy buying a home in this surprise suburb could save you $400,000
-
Noosa News19 hours agoUte driver charged with manslaughter over deaths of father and son in Logan, south of Brisbane
-
Business18 hours agoBell Potter names cheap ASX dividend shares to buy now
-
Noosa News19 hours agoUncertainty still surrounds government pay deals with police, teachers, and nurses and midwives